IgG Antibodies against SARS-CoV-2 Correlate with Days from Symptom Onset, Viral Load and IL-10
Mary K. Young, Christine Kornmeier, Rebecca M. Carpenter, Nick R. Natale, Jennifer M. Sasson, Michael D. Solga, Amy J. Mathers, Melinda D. Poulter, Xiao Qiang, William A. Petri Jr.
doi: https://doi.org/10.1101/2020.12.05.20244541
Mary K. Young
1Department of Medicine, University of Virginia Health System, Charlottesville, VA, 22908, USA
Christine Kornmeier
2MilliporeSigma, St. Louis, MO, 63103, USA
Rebecca M. Carpenter
1Department of Medicine, University of Virginia Health System, Charlottesville, VA, 22908, USA
Nick R. Natale
3Department of Neuroscience, University of Virginia Health System, Charlottesville, VA, 22908, USA
Jennifer M. Sasson
1Department of Medicine, University of Virginia Health System, Charlottesville, VA, 22908, USA
Michael D. Solga
4UVA Flow Cytometry Core, University of Virginia, Charlottesville, VA, 22908, USA
Amy J. Mathers
1Department of Medicine, University of Virginia Health System, Charlottesville, VA, 22908, USA
Melinda D. Poulter
6Department of Pathology, University of Virginia Health System, Charlottesville, VA, 22908, USA
Xiao Qiang
2MilliporeSigma, St. Louis, MO, 63103, USA
William A. Petri Jr.
1Department of Medicine, University of Virginia Health System, Charlottesville, VA, 22908, USA
5Department of Microbiology, Immunology and Cancer Biology, University of Virginia Health System, Charlottesville, VA, 22908, USA
6Department of Pathology, University of Virginia Health System, Charlottesville, VA, 22908, USA
Data Availability
The data will be available online when the peer-reviewed manuscript is published.
Posted December 07, 2020.
IgG Antibodies against SARS-CoV-2 Correlate with Days from Symptom Onset, Viral Load and IL-10
Mary K. Young, Christine Kornmeier, Rebecca M. Carpenter, Nick R. Natale, Jennifer M. Sasson, Michael D. Solga, Amy J. Mathers, Melinda D. Poulter, Xiao Qiang, William A. Petri Jr.
medRxiv 2020.12.05.20244541; doi: https://doi.org/10.1101/2020.12.05.20244541
IgG Antibodies against SARS-CoV-2 Correlate with Days from Symptom Onset, Viral Load and IL-10
Mary K. Young, Christine Kornmeier, Rebecca M. Carpenter, Nick R. Natale, Jennifer M. Sasson, Michael D. Solga, Amy J. Mathers, Melinda D. Poulter, Xiao Qiang, William A. Petri Jr.
medRxiv 2020.12.05.20244541; doi: https://doi.org/10.1101/2020.12.05.20244541
Subject Area
Subject Areas
- Addiction Medicine (317)
- Allergy and Immunology (621)
- Anesthesia (162)
- Cardiovascular Medicine (2318)
- Dermatology (205)
- Emergency Medicine (373)
- Epidemiology (11653)
- Forensic Medicine (10)
- Gastroenterology (688)
- Genetic and Genomic Medicine (3656)
- Geriatric Medicine (344)
- Health Economics (625)
- Health Informatics (2341)
- Health Policy (922)
- Hematology (337)
- HIV/AIDS (765)
- Medical Education (362)
- Medical Ethics (102)
- Nephrology (394)
- Neurology (3407)
- Nursing (193)
- Nutrition (512)
- Oncology (1788)
- Ophthalmology (529)
- Orthopedics (212)
- Otolaryngology (284)
- Pain Medicine (227)
- Palliative Medicine (66)
- Pathology (442)
- Pediatrics (1015)
- Primary Care Research (411)
- Public and Global Health (6047)
- Radiology and Imaging (1243)
- Respiratory Medicine (816)
- Rheumatology (373)
- Sports Medicine (319)
- Surgery (392)
- Toxicology (50)
- Transplantation (171)
- Urology (144)